Search

Search Results
Results 6821 - 6830 of 6900 for A-fil
  • Mobic
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Mobic intended for persons living in Australia.
  • Classification of cleanrooms for the pharmaceutical industry
    White Paper - 6 Dec 2023
    Pharmaceuticals must be manufactured to meet high standards of efficacy and quality. This article explores the classification of cleanrooms for the pharmaceutical industry.
  • Xyntha
    Drug - 31 Mar 2023
    Consumer Medicine Information (CMI) about Xyntha intended for persons living in Australia.
  • BeneFIX
    Drug - 20 Dec 2022
    Consumer Medicine Information (CMI) about BeneFIX intended for persons living in Australia.
  • Braltus
    Drug - 26 May 2022
    Consumer Medicine Information (CMI) about Braltus intended for persons living in Australia.
  • Spiriva
    Drug - 6 Jul 2021
    Consumer Medicine Information (CMI) about Spiriva intended for persons living in Australia.
  • Alzheimer’s Disease: Rethinking The Basics
    White Paper - 17 May 2021
    Count to three: “one-one-thousand, two-one-thousand, three-one-thousand”. Three seconds. This is how long it takes for another person to develop dementia somewhere in the world (Alzheimer’s Disease...
  • Overcoming the Contamination of Polychlorinated Biphenyls in Water with Automated Solid Phase Extraction
    White Paper - 3 Nov 2020
    Polychlorinated Biphenyls (PCB) are a worldwide contamination problem.
  • Extracting EPA Method 625.1 Semi-Volatile Analytes from Wastewater
    White Paper - 31 Oct 2020
    Biotage extracts EPA Method 625.1 semi-volatile analytes from wastewater by using the Biotage® Horizon 5000, DryDisk® Solvent Drying System and TurboVap® II.
  • Valcyte Powder for Oral Solution
    Drug - 15 Oct 2020
    Consumer Medicine Information (CMI) about Valcyte Powder for Oral Solution (valganciclovir) intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback